Delaware
(State or Other Jurisdiction of Incorporation)
|
0-22179
(Commission File Number)
|
58-2029543
(IRS Employer Identification No.)
|
5835 Peachtree Corners East, Suite D
Norcross, Georgia
(Address of Principal Executive Offices)
|
30092
(Zip Code)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Exhibit No. | Description | |
10.1 | Assigned Task Agreement | |
10.2 | Agreement for Collaboration in the Development of Sectroscopic technology | |
99.1 | Press Release Dated March 30, 2011 Releasing Financial Results for the Fourth Quarter | |
99.2 | Press Release Dated March 30, 2011 Announcing Agreements with Konica Minolta Opto | |
99.3 | Conference call script dated March 31, 2010 |
GUIDED THERAPEUTICS, INC | |||
By: | /s/ MARK L. FAUPEL | ||
Mark L. Faupel, Ph.D. | |||
CEO & President | |||
Date: April 1, 2011 |